763 related articles for article (PubMed ID: 26245379)
21. Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints.
Pogozheva ID; Lomize AL; Mosberg HI
Biophys J; 1998 Aug; 75(2):612-34. PubMed ID: 9675164
[TBL] [Abstract][Full Text] [Related]
22. Molecular insights into the biased signaling mechanism of the μ-opioid receptor.
Cong X; Maurel D; Déméné H; Vasiliauskaité-Brooks I; Hagelberger J; Peysson F; Saint-Paul J; Golebiowski J; Granier S; Sounier R
Mol Cell; 2021 Oct; 81(20):4165-4175.e6. PubMed ID: 34433090
[TBL] [Abstract][Full Text] [Related]
23. Distinct domains of the mu-opioid receptor control uncoupling and internalization.
Celver J; Xu M; Jin W; Lowe J; Chavkin C
Mol Pharmacol; 2004 Mar; 65(3):528-37. PubMed ID: 14978231
[TBL] [Abstract][Full Text] [Related]
24. Molecular dynamics of fentanyl bound to μ-opioid receptor.
Lipiński PFJ; Jarończyk M; Dobrowolski JC; Sadlej J
J Mol Model; 2019 May; 25(5):144. PubMed ID: 31053968
[TBL] [Abstract][Full Text] [Related]
25. Helix 3 acts as a conformational hinge in Class A GPCR activation: An analysis of interhelical interaction energies in crystal structures.
Lans I; Dalton JAR; Giraldo J
J Struct Biol; 2015 Dec; 192(3):545-553. PubMed ID: 26522273
[TBL] [Abstract][Full Text] [Related]
26. Do crystal structures obviate the need for theoretical models of GPCRs for structure-based virtual screening?
Tang H; Wang XS; Hsieh JH; Tropsha A
Proteins; 2012 Jun; 80(6):1503-21. PubMed ID: 22275072
[TBL] [Abstract][Full Text] [Related]
27. How Oliceridine (TRV-130) Binds and Stabilizes a μ-Opioid Receptor Conformational State That Selectively Triggers G Protein Signaling Pathways.
Schneider S; Provasi D; Filizola M
Biochemistry; 2016 Nov; 55(46):6456-6466. PubMed ID: 27778501
[TBL] [Abstract][Full Text] [Related]
28. GPCR engineering yields high-resolution structural insights into beta2-adrenergic receptor function.
Rosenbaum DM; Cherezov V; Hanson MA; Rasmussen SG; Thian FS; Kobilka TS; Choi HJ; Yao XJ; Weis WI; Stevens RC; Kobilka BK
Science; 2007 Nov; 318(5854):1266-73. PubMed ID: 17962519
[TBL] [Abstract][Full Text] [Related]
29. Fentanyl Family at the Mu-Opioid Receptor: Uniform Assessment of Binding and Computational Analysis.
Lipiński PFJ; Kosson P; Matalińska J; Roszkowski P; Czarnocki Z; Jarończyk M; Misicka A; Dobrowolski JC; Sadlej J
Molecules; 2019 Feb; 24(4):. PubMed ID: 30791394
[TBL] [Abstract][Full Text] [Related]
30. Backbone NMR reveals allosteric signal transduction networks in the β1-adrenergic receptor.
Isogai S; Deupi X; Opitz C; Heydenreich FM; Tsai CJ; Brueckner F; Schertler GF; Veprintsev DB; Grzesiek S
Nature; 2016 Feb; 530(7589):237-41. PubMed ID: 26840483
[TBL] [Abstract][Full Text] [Related]
31. Universal Properties and Specificities of the β
Mitra A; Sarkar A; Borics A
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638767
[TBL] [Abstract][Full Text] [Related]
32. Opioid peptide receptor studies. 14. Stereochemistry determines agonist efficacy and intrinsic efficacy in the [(35)S]GTP-gamma-S functional binding assay.
Xu H; Hashimoto A; Rice KC; Jacobson AE; Thomas JB; Carroll FI; Lai J; Rothman RB
Synapse; 2001 Jan; 39(1):64-9. PubMed ID: 11071711
[TBL] [Abstract][Full Text] [Related]
33. 17-Cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6β-(4'-pyridylcarboxamido)morphinan (NAP) Modulating the Mu Opioid Receptor in a Biased Fashion.
Zhang Y; Williams DA; Zaidi SA; Yuan Y; Braithwaite A; Bilsky EJ; Dewey WL; Akbarali HI; Streicher JM; Selley DE
ACS Chem Neurosci; 2016 Mar; 7(3):297-304. PubMed ID: 26716358
[TBL] [Abstract][Full Text] [Related]
34. Structure of the adenosine A(2A) receptor bound to an engineered G protein.
Carpenter B; Nehmé R; Warne T; Leslie AG; Tate CG
Nature; 2016 Aug; 536(7614):104-7. PubMed ID: 27462812
[TBL] [Abstract][Full Text] [Related]
35. Design, synthesis, pharmacological evaluation and molecular dynamics of β-amino acids morphan-derivatives as novel ligands for opioid receptors.
Nieto CT; Gonzalez-Nunez V; Rodríguez RE; Diez D; Garrido NM
Eur J Med Chem; 2015 Aug; 101():150-62. PubMed ID: 26134550
[TBL] [Abstract][Full Text] [Related]
36. Molecular dynamics simulations of the effect of the G-protein and diffusible ligands on the β2-adrenergic receptor.
Goetz A; Lanig H; Gmeiner P; Clark T
J Mol Biol; 2011 Dec; 414(4):611-23. PubMed ID: 22037586
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a novel bivalent morphinan possessing kappa agonist and micro agonist/antagonist properties.
Mathews JL; Peng X; Xiong W; Zhang A; Negus SS; Neumeyer JL; Bidlack JM
J Pharmacol Exp Ther; 2005 Nov; 315(2):821-7. PubMed ID: 16076937
[TBL] [Abstract][Full Text] [Related]
38. The atomistic level structure for the activated human κ-opioid receptor bound to the full Gi protein and the MP1104 agonist.
Mafi A; Kim SK; Goddard WA
Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5836-5843. PubMed ID: 32127473
[TBL] [Abstract][Full Text] [Related]
39. Sortase ligation enables homogeneous GPCR phosphorylation to reveal diversity in β-arrestin coupling.
Staus DP; Wingler LM; Choi M; Pani B; Manglik A; Kruse AC; Lefkowitz RJ
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3834-3839. PubMed ID: 29581292
[TBL] [Abstract][Full Text] [Related]
40. Revealing Atomic-Level Mechanisms of Protein Allostery with Molecular Dynamics Simulations.
Hertig S; Latorraca NR; Dror RO
PLoS Comput Biol; 2016 Jun; 12(6):e1004746. PubMed ID: 27285999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
